Author: Andrew Rogers
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
The Co-op has instructed staff to boost the visibility and promotion of vape products in its stores as part of a drive to recover sales following a major cyber-attack earlier this year. According to an internal document seen by The Guardian, the retailer is increasing vape displays, expanding product ranges, and adding new advertising to attract customers who turned to rival shops after the April hack disrupted operations and supply chains. The strategy, titled Powering Up: Focus Sprint: Cigs, Tobacco and Vape, states that sales in this category have not returned to pre-cyber levels, with “£1m missing sales per week”…
Experts are urging the UK government to introduce cigarette-style health warnings on bacon and ham, warning that chemicals used in curing these meats can cause bowel cancer. The call comes 10 years after the World Health Organization (WHO) classified processed meats as carcinogenic to humans, placing them in the same category as tobacco and asbestos. Despite this, scientists say successive governments have done “virtually nothing” to reduce the risks posed by nitrites, which are added to preserve processed meats and give them their pink colour. According to researchers, inaction over the past decade has led to 54,000 bowel cancer cases…
The weight-loss drug semaglutide – the active ingredient in Wegovy – reduces the risk of heart attack and stroke regardless of how much weight people lose, according to a major global study published in The Lancet. The trial, led by researchers at University College London (UCL), analysed data from 17,604 adults aged 45 and over who were overweight or obese. Participants were given either weekly semaglutide injections or a placebo across 41 countries. The study confirmed that semaglutide lowers the risk of major cardiac events by 20%, even in patients who lost little or no weight. This suggests the drug…
A large UK study has revealed that different antidepressants can cause strikingly different side-effects, particularly when it comes to weight gain, heart rate, and blood pressure. Researchers from King’s College London and the University of Oxford analysed data from 151 clinical trials involving more than 58,000 participants taking 30 types of antidepressants. They found that while some drugs can lead to significant physical changes within just eight weeks, others have minimal effects. The study showed a 4kg difference in average weight change between certain drugs. People taking agomelatine tended to lose around 2.5kg, while those on maprotiline gained about 2kg.…
Sixty-eight Pizza Hut restaurants across the UK are set to close after the company behind its UK operations fell into administration. The affected sites range from Finchley Lido in London to Carlisle in Cumbria and Rhyl in north Wales. In addition, 11 delivery-only outlets will shut down, putting 1,210 jobs at risk. DC London Pie, which operated Pizza Hut’s UK restaurants under a franchise agreement, appointed administrators from FTI Consulting on Monday. However, there was some good news for the brand. US parent company Yum! Brands — which also owns KFC and Taco Bell — stepped in to buy 64…
Millions of young people could miss out on safe and effective treatments because so few take part in medical research, new data shows. People aged 18–24 make up 8% of England’s population but only 4.4% of participants in health studies, according to the National Institute for Health and Care Research (NIHR). Experts warn this underrepresentation means treatments are often tested mainly on older adults, making them less suitable for younger patients. “Young people face unique physical and mental health challenges,” said Kirsty Blenkins of the Association for Young People’s Health. “If research excludes them, it risks poorer outcomes and widening…
A new “smart” injection has shown remarkable results in shrinking head and neck cancer tumours within just six weeks, offering fresh hope for patients with advanced disease. The drug, amivantamab, was tested in a major international trial and could transform treatment for people whose cancer has returned or spread after standard therapies such as chemotherapy and immunotherapy. Head and neck cancer is the sixth most common cancer globally. Once it recurs, treatment options are limited — but researchers say amivantamab may change that. Presented at the European Society for Medical Oncology conference in Berlin, the trial found that 76% of…
Paramount Skydance plans to lay off about 2,000 U.S. employees starting the week of 27 October as part of a $2 billion cost-cutting initiative under new CEO David Ellison, Variety reported on Saturday. The cuts come just months after Skydance Media completed its $8.4 billion merger with Paramount Global in August. Additional international layoffs are also expected, with full details to be shared in the company’s third-quarter earnings report on 10 November. A previous Variety report in August suggested that between 2,000 and 3,000 jobs could be eliminated by early November. As of December 2024, Paramount employed nearly 18,600 full-…
Prologis, a leading warehouse-focused real estate investment trust based in San Francisco, reported strong growth in the third quarter of 2025. The company exceeded Wall Street expectations for both revenue and core funds from operations. Analysts had predicted modest growth, but Prologis outperformed due to robust leasing activity across its global portfolio. During the quarter, Prologis signed a record 62 million square feet of new leases. This represents one of the highest levels of warehouse leasing in the company’s history. The strong demand reflects a growing need for logistics and distribution space, fueled by the expansion of e-commerce and supply…
A long-acting injection to prevent HIV is set to be approved for use in England and Wales, offering a major new alternative to daily oral medication. The treatment, known as cabotegravir (CAB-LA), is administered every two months and provides pre-exposure prophylaxis (Prep) for HIV-negative people at risk of infection. It is already available through the NHS in Scotland. In new draft guidance, the National Institute for Health and Care Excellence (Nice) recommended CAB-LA for adults and young people who cannot take oral Prep due to medical or practical reasons. Health secretary Wes Streeting hailed the move as “gamechanging.” He said,…
